Bio-Rad Points To Worker Pacts In Battling 10X Fed. Circ. Win
Bio-Rad Laboratories Inc. wants the full Federal Circuit to review a panel's decision confirming that the company infringed three 10X Genomics' gene sequencing patents, arguing that the ruling failed to give...To view the full article, register now.
Already a subscriber? Click here to view full article